CLOV CLOVER HEALTH INV CORP

Clover Health to Present at Canaccord Genuity 43rd Annual Growth Conference and 2023 Wells Fargo Healthcare Conference

Clover Health to Present at Canaccord Genuity 43rd Annual Growth Conference and 2023 Wells Fargo Healthcare Conference

FRANKLIN, Tenn., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced its participation in the following investor conferences:

  • CEO, Andrew Toy, will present at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, August 9, 2023, at 8:00 a.m. Eastern Time.
  • CFO, Scott J. Leffler, will present at the 2023 Wells Fargo Healthcare Conference on Wednesday, September 6, 2023, at 10:15 a.m. Eastern Time.

A live webcast and reply of the presentations will be accessible from Clover Health's investor relations website at .

About Clover Health:

Clover Health (Nasdaq: CLOV) is a physician enablement company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. We operate two distinct lines of business: Insurance and Non-Insurance. Through our Insurance line of business, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. Our Non-Insurance line of business similarly aims to reduce cost-of-care while enhancing the quality of care for patients enrolled in Original Medicare.

Press Contact:

Andrew Still-Baxter

Investor Relations Contact:

Ryan Schmidt



EN
02/08/2023

Underlying

CLOVCLOVER HEALTH INV CORP

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CLOVER HEALTH INV CORP

 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Clover Health Set to Join Russell 3000® Index

Clover Health Set to Join Russell 3000® Index WILMINGTON, Del., June 30, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), announced that it is set to join the broad-market Russell 3000® Index, effective after the US market opens today, June 30, 2025, as part of the 2025 Russell indexes reconstitution. Annual reconstitution of the Russell indexes captures the 4,000 largest US stocks as of April 30, 2025, ranking them by total market capitalization. Membership in the Russell 3000® Index, which remains in place for one year, also results in automat...

June 30, 2025 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Clover Health Reports First Quarter 2025 Results and Improves Full Yea...

Clover Health Reports First Quarter 2025 Results and Improves Full Year 2025 Guidance First quarter 2025 Medicare Advantage membership of 103,418, up 30% year-over-yearFirst quarter 2025 Total revenues of $462 million, up 33% year-over-yearMedicare Advantage medical costs are in line with expectations, underscoring the strength of Clover’s technology-first care management modelMeaningful improvement across first quarter 2025 profitability metrics: GAAP Net loss of $1 million, as compared to a GAAP Net loss of $19 million a year agoAdjusted EBITDA of $26 million, up 279% year-over-yearAdjust...

May 6, 2025 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Primary Care Physician Use of Counterpart Assistant Technology Associa...

Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure New whitepaper highlights how a relationship with a Primary Care Physician (“PCP”) that uses Counterpart Assistant is associated with better clinical management, and fewer hospitalizations (18% lower) and readmissions (25% lower) in heart failure patients WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Heal...

May 1, 2025 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Clover Health Announces Changes to Board of Directors

Clover Health Announces Changes to Board of Directors Thomas L. Tran will become Chairman of the Audit Committee and the Nominating and Corporate Governance Committee, and Lee A. Shapiro will not stand for re-election at the 2025 Annual Shareholders’ Meeting WILMINGTON, Del., April 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that after four years of distinguished service, Lee A. Shapiro, a member of Clover Health’s Board of Directors, has notified the Company of his intention not to stand for ...

April 22, 2025 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Clover Health to Participate in Upcoming Investor Conferences

Clover Health to Participate in Upcoming Investor Conferences WILMINGTON, Del., April 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following investor conferences: CFO, Peter Kuipers, will present at the 2025 Bank of America Healthcare Conference on Wednesday, May 14, 2025, at 6:00 p.m. Eastern Time. A live webcast and replay of the presentation will be accessible from Clover Health's investor relations website at .CFO, Peter Kuipers, will participate in the 22nd Annual C...

April 21, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch